Ange Maguy is the head of “Atrial Fibrillation and Therapeutic Innovation” at the Department of Physiology, Faculty of Medicine, University of Bern, Switzerland. He graduated his PhD in Physiology and Pharmacology at the University of Paris-Saclay and performed his post-doctoral fellowship at the electrophysiology research program of Montreal Heart Institute. His translational research focuses on deciphering the substrate of atrial fibrillation (patient samples, small to large animal models) using state-of-the-art methods ranging from electrophysiological studies to multiomics approaches. Unveiling key therapeutic avenues is a core driver of his research. He was honored with the Pfizer Research Prize in 2021. In addition to teaching activities, he is an active member of the nucleus of the ESC Working Group on Cellular Biology of the Heart and serves as secretary to communication in the executive board of the GRRC (French Society of Cardiology).